Dermira (DERM) Tops Q1 EPS by 5c

Dermira (NASDAQ: DERM) reported Q1 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $16 million versus the consensus estimate of $20.42 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Omega Flex (OFLX) Tops Q2 EPS by 27c
• Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance